Wednesday, 30 September 2026Updated 1m ago
← Top stories
Legal▼ Bearish for Aurobindo Pharma

GST appellate authority upholds ₹4.6 crore ITC claim order against Aurobindo Pharma

2 sources · first seen 08:34 30 Sept · updated 09:52 30 Sept

The brief

Written from 2 reports · check the source before you trade
  • GST appellate authority upheld a ₹4.6 crore ITC claim order against Aurobindo Pharma
  • The order relates to FY2020-21 under the Central GST Act and Telangana GST Act
  • The tax order adds a compliance overhang for Aurobindo Pharma and Indian pharma investors

Tags on this story

Pick a tag to see all its stories
Aurobindo Pharma₹1,697.70 · 1 todayGST6 todayTaxes26 todayPharma and healthcare40 today

Linked by the tag GST

36 stories this week
  1. 27 SeptGST Council to simplify processes, cut penaltiesPolicy · 1 source
  2. 25 SeptAnother price hike inevitable due to higher input costs: Tata Motors PV MD Shailesh Chandra1 source · Tata Motors PV MD Shailesh Chandra says another price hike is inevitable due to higher input costs
  3. 25 SeptGST Council’s October 7 meeting to focus on process reforms; no broad rate changes expectedPolicy · 3 sources · The Council is expected to review implementation of GST rate changes over the past year
  4. 25 SeptBuzzing Stocks: ESDS Software slips 5% despite 14% profit jump; JSW Cement falls on ₹230 crore GST noticeMarket move · 1 source
  5. 24 SeptGST Council to review proposed levy on UPI merchant fees above ₹2,000Policy · 2 sources · The GST Council is scheduled to meet on October 7 to discuss the levy
All GST stories →

Read the reports

2 reports · earliest 08:34
Business LineGST appellate authority upholds ₹4.6 crore ITC claim order against Aurobindo Pharma08:34MoneycontrolAurobindo Pharma gets Rs 4.60-crore GST setback as appellate authority upholds ITC demand09:52